Phibro Animal Health
PAHC
191 hedge funds and large institutions have $651M invested in Phibro Animal Health in 2018 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 80 increasing their positions, 63 reducing their positions, and 22 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 63
5% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 22
0.56% more ownership
Funds ownership: 99.62% → 100.19% (+0.56%)
0% more funds holding
Funds holding: 191 → 191 (0)
25% less capital invested
Capital invested by funds: $864M → $651M (-$213M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$3.79M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$3.54M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.53M |
| 4 |
FIM
Foresters Investment Management
New York
|
+$2.44M |
| 5 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$2.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$9.03M |
| 2 |
BlackRock
New York
|
-$2.66M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$2.64M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.4M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$2.13M |
PAHC Hedge Fund Activity: Q4 2018 in Review
191 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2018, worth a combined $651M — down 25% from $864M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new PAHC positions and 22 closed out — a net gain of 1 holder — while 80 added to existing stakes and 63 trimmed.
The largest buyer was Wells Fargo, adding an estimated $3.79M. The largest seller was Morgan Stanley, cutting an estimated $9.03M.
- 191 institutional investors held Phibro Animal Health (PAHC) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $651M of Phibro Animal Health stock for Q4 2018, down 25% quarter-over-quarter.
- 23 funds opened new Phibro Animal Health positions in Q4 2018 and 22 closed out, a net change of +1 holder.
- The largest Phibro Animal Health buyer in Q4 2018 was Wells Fargo, an estimated $3.79M added.
- The largest Phibro Animal Health seller in Q4 2018 was Morgan Stanley, an estimated $9.03M sold.
Based on aggregated 13F filings for Q4 2018.